New brand drug - Pavblu (aflibercept intravitreal)

Pavblu (aflibercept intravitreal) - indicated for 1) neovascular age-related macular degeneration; 2) retinal vein occlusion-associated macular edema; 3) diabetic macular edema; and 4) diabetic retinopathy.